Opportunity
SAM #JA-26-Edg-0436
Sole Source Justification for Technical Report Writing Services (Phase II Clinical Trial)
Buyer
W6QK ACC-APG
Posted
August 28, 2026
Identifier
JA-26-Edg-0436
NAICS
541715, 541990
This opportunity is a sole source justification for technical report writing services related to a Phase II clinical trial study for the Department of the Army. - Sole source contract awarded to PPD Development, L.P. (subsidiary of Thermo Fisher Scientific) - PPD holds exclusive proprietary data and validated methods from the completed study - Services required: Preparation of final QA-reviewed bioanalytical sample analysis reports - Reports are needed to support regulatory submissions to the FDA - Includes reactivation of dormant projects and generation of final deliverables - No competition or subcontracting possible due to exclusive data ownership - No specific products, part numbers, or purchase quantities listed - One-time contract action; no follow-on contracts planned - Period of performance: Final deliverables required for FDA submission, document dated June 2025
Description
The purpose of this other than full and open competition contract to PPD Development, L.P. to have technical reports written for a completed study using data PPD attained during performance of the study.